Susanne B Haga

Associate Professor in Medicine

Office: 
101 Science Drive, Box 3382 CIEMAS Suite 2121, Durham, NC 27708
Campus Box: 
101 Science Drive - CIEMAS Bld, Box 3382, Durham, NC 27708
Phone: 
(919) 684-0325
Email: 
susanne.haga@duke.edu
Susanne B Haga
My research interests focus on issues affecting the translation of genomics to clinical practice. Specifically, I have a strong interest in education, with each of my research projects involving some component of professional, public or patient education, including development of educational materials about genomic research in general, pharmacogenetic testing, and communicating genetic test results, in addition to undergraduate teaching in genetics/genomics, ethics, and policy. Areas of expertise: Bioethics and Health Behavior

Education

  • Ph.D., University of Maryland, Baltimore 1999

Ginsburg, G. S., and S. B. Haga. “Foundations and application of precision medicine.” In Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Foundations, 21–45, 2018. https://doi.org/10.1016/B978-0-12-812537-3.00002-0. Full Text

Haga, S. B. “Precision Medicine and Challenges in Research and Clinical Implementation.” In Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition, 717–32, 2017. https://doi.org/10.1016/B978-0-12-803506-1.00021-8. Full Text

Haga, S. B. “Overview of Policy, Ethical, and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Precision Medicine: Primary Care: Third Edition, 19–43, 2017. https://doi.org/10.1016/B978-0-12-800685-6.00005-9. Full Text

Haga, S. B. “Overview of Policy, Ethical and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Personalized Medicine, 1:392–404, 2013. https://doi.org/10.1016/B978-0-12-382227-7.00034-3. Full Text

Haga, S. B. “Genome Policy Considerations for Genomic Medicine.” In Essentials of Genomic and Personalized Medicine, 209–22, 2010. https://doi.org/10.1016/B978-0-12-374934-5.00018-0. Full Text

Haga, S. B. “From Sequence to Genomic Medicine: Genome Policy Considerations.” In Genomic and Personalized Medicine, Two-Vol Set, 387–400, 2009. https://doi.org/10.1016/B978-0-12-369420-1.00033-0. Full Text

Brown, Lisa, Seenae Eum, Susanne B. Haga, Jeffrey R. Strawn, and Heather Zierhut. “Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.” Pharmacopsychiatry 53, no. 4 (July 2020): 162–73. https://doi.org/10.1055/a-0975-9595. Full Text

Haga, Susanne B. “Toward digital-based interventions for medication adherence and safety.” Expert Opin Drug Saf 19, no. 6 (June 2020): 735–46. https://doi.org/10.1080/14740338.2020.1764935. Full Text

Haga, Susanne B., and Lori A. Orlando. “The enduring importance of family health history in the era of genomic medicine and risk assessment.” Per Med 17, no. 3 (May 1, 2020): 229–39. https://doi.org/10.2217/pme-2019-0091. Full Text Open Access Copy

Haga, Susanne B., Ryan Shaw, Charles Kneifel, Sarah J. Bond, and Geoffrey S. Ginsburg. “Promoting Wellness Through Mobile Health Technology in a College Student Population: Protocol Development and Pilot Study.” Jmir Res Protoc 9, no. 4 (April 3, 2020): e16474. https://doi.org/10.2196/16474. Full Text

Haga, Susanne B. “Managing Increased Accessibility to Pharmacogenomic Data.” Clin Pharmacol Ther 106, no. 5 (November 2019): 922–24. https://doi.org/10.1002/cpt.1602. Full Text

Weitzel, Kristin Wiisanen, Benjamin Q. Duong, Meghan J. Arwood, Aniwaa Owusu-Obeng, Noura S. Abul-Husn, Barbara A. Bernhardt, Brian Decker, et al. “A stepwise approach to implementing pharmacogenetic testing in the primary care setting.” Pharmacogenomics 20, no. 15 (October 2019): 1103–12. https://doi.org/10.2217/pgs-2019-0053. Full Text

Haga, Susanne B. “First Responder to Genomic Information: A Guide for Primary Care Providers.” Molecular Diagnosis & Therapy 23, no. 4 (August 2019): 459–66. https://doi.org/10.1007/s40291-019-00407-z. Full Text

Villegas, Catalina, and Susanne B. Haga. “Access to Genetic Counselors in the Southern United States.” J Pers Med 9, no. 3 (July 1, 2019). https://doi.org/10.3390/jpm9030033. Full Text

Haga, Susanne B., and Yiling Liu. “Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.” Pharmacogenomics 20, no. 8 (June 2019): 581–87. https://doi.org/10.2217/pgs-2019-0006. Full Text

Haga, Susanne B., and Jivan Moaddeb. “Pharmacogenomics courses in pharmacy school curricula.” Pharmacogenomics 20, no. 9 (June 2019): 625–30. https://doi.org/10.2217/pgs-2019-0024. Full Text

Pages

Selected Grants

Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations. awarded by National Institutes of Health (Investigator). 2018 to 2023

Preparing Genetic Counselors for Genomic Medicine Research awarded by National Institutes of Health (Principal Investigator). 2017 to 2022

IRES Track 1 IRTG Engaged in Dissecting and Reengineering the Regulatory Genome awarded by National Science Foundation (Associate Director). 2019 to 2022

Postdoctoral Training in Genomic Medicine Research awarded by National Institutes of Health (Co-Principal Investigator). 2017 to 2021

Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health (Principal Investigator). 2011 to 2020

VGER, The Vanderbilt Genome-Electronic Records Project awarded by Vanderbilt University Medical Center (Investigator). 2018 to 2020

IPA -Rachel Mills awarded by Durham Veterans Affairs Medical Center (Principal Investigator). 2019

Impact of Personal Genomic Testing on Primary Care Physician Knowledge and Attitudes awarded by 23andMe, Inc (Principal Investigator). 2017 to 2018

Genetic Risk Testing & Health Coaching for T2D and CHD awarded by Air Force Office of Scientific Research (Co Investigator). 2013 to 2017

Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health (Principal Investigator). 2007 to 2015

Pages